Veritas In Silico is unveiling the mysteries of RNA and harnessing the potential of messenger RNA (mRNA) as a drug target. Powered by our proprietary in silico technology, we have established an entirely new system for drug discovery that focuses on finding drugs against structural motifs on mRNA.
The discovery of drugs that target mRNA is a promising direction for drug development and a new paradigm for the pharmaceutical industry. It has the potential for application to any disease, including those for which conventional protein-targeted discovery has not yielded effective treatments.
Veritas In Silico’s mission is to build a society where every patient, especially those with diseases that currently have no satisfactory treatment, can look forward to a brighter future through the realization of mRNA-targeted drugs.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Nishigotanda 1-11-1, Shiagawa-Ku,tokyo 141-0031,japan
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Runcorn.
- HQ
- Shiagawa-ku, Tokyo
Veritas In Silico Inc. Questions
Veritas In Silico Inc.'s website is https://www.veritasinsilico.com/en/
Veritas In Silico Inc.'s LinkedIn profile is https://jp.linkedin.com/company/veritasinsilico
Veritas In Silico Inc. has
11 employees.
View email and phone details for 11
employees at Veritas In Silico Inc..
Veritas In Silico Inc.'s industry is
Pharmaceutical Manufacturing
Veritas In Silico Inc.'s top competitors are
Torch Inc.,
Epsilon Molecular Engineering Inc.,
The Heath Business & Technical Park,
Rallybio,
Reborna Biosciences, Inc.,
トステム（株）,
あすか製薬（株）,
Lcc Technologies Ltd,
Shonan Health Innovation Park,
Enamine Ltd..
Veritas In Silico Inc.'s categories are Pharmaceutical Manufacturing
Veritas In Silico Inc.'s founding year is 2016
